Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem.
نویسندگان
چکیده
This study concerns the molecular characterization of beta-thalassemia (beta-thal) alleles in 210 chromosomes. In the studied population, mutations were detected in 98% of the beta-thalassemic chromosomes. Twenty-one molecular defects have been found, where the five dominant mutations, IVS-I-110 (G>A), nonsense mutation at codon 39 (C>T), the frameshift codon (FSC) 6 (-A), IVS-I-1 (G>A), and IVS-I-6 (T>C), account for 80% of the independent chromosomes. Among the remaining alleles, 16 different mutations were identified, half of them being described for the first time in Algeria. These include the -101 (C>T) and the -90 (C>T) mutations in the distal and proximal promoter elements, respectively, the FSC 8 (-AA), IVS-I-5 (G>T), IVS-I-128 (T>G), FSC 47 (+A), IVS-II-1 (G>A), and the substitution in the polyadenylation signal (poly A) site AATAAA>AATGAA. Haplotype analyses on rare variants were performed. The possible origin of these mutations either by founder effect or by migrations is discussed, and raises the question of an adequate strategy to be used adapted to socio-economical status.
منابع مشابه
The mediating role of hope in relations between spiritual well-being and resilience among adolescents with beta thalassemia major: a structural equation modeling approach
Introduction: Patients with beta thalassemia major face various challenges in physical and psychosocial aspects. The need for resilience capacity to overcome these challenges can be effective. Identifying factors affecting resilience can be considered as a framework for designing nursing interventions. The present study was conducted with the aim of determining the mediating role of hope in the...
متن کاملIdentification of a Neonate with Thalassemia Intermedia Despite Premarital Screening Program in Mazandaran Province (Co-inheritance of Hb Knossos and IVS II-1 G> A Mutations)
Background: Beta thalassemia is a common health problem in Iran especially in Northern provinces. Premarital screening for thalassemia is compulsory in Iran and identification of the carriers is based on primary CBC (Cell Blood Count) and hemoglobin electrophoresis. Silent mutations on β-globin gene have borderline or normal hematological indices that cannot be detected in premarital scree...
متن کاملPrevalence of Heart Failure in the Cases of Beta-thalassemia Major; Two Years Follow-Up
Inroduction: Heart failure (HF) is an important cause of morbidity and mortality in the cases of Beta-thalassemia major. The purpose of this study was to estimate HF prevalence in these patients and to assess the survivability of those who were treated with intensive chelating therapy. Design and methods: This cross sectional study included 72 beta-thalassemia major cases, the mean age at t...
متن کاملQuality of life among patients with beta-thalassemia major in Shahrekord city, Iran
Background and aims: Nowadays introduction of regular blood transfusion therapy has obviously improved the life expectancy of patients with thalassemia. However, these patients face with newer challenges which influence their quality of life (QoL). In this study, the aim of this study was to measure QoL among patients with β-thalassemia major (β-TM). Methods:</str...
متن کاملغربالگری پیش از ازدواج بتا تالاسمی در شهرستان ارومیه در سال 1393: یک گزارش کوتاه
Background and Objective: Beta thalassemia is one of the most prevalent genetic disorders in Iran. Nowadays the premarital screening program for beta thalassemia has brought the highest concern and attention in our country to prevent any child birth affected by the major thalassemia.Thalassemia major leads to serious medical, social, and economic problems for patients and their families, and pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Hemoglobin
دوره 33 1 شماره
صفحات -
تاریخ انتشار 2009